| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Common Stock | Sale | -$7.5K | -58 | -30.37% | $129.33 | 133 | Oct 4, 2021 | Direct | F1 |
| transaction | CNMD | Common Stock | Sale | -$10.5K | -81 | -60.9% | $130.13 | 52 | Oct 4, 2021 | Direct | F2 |
| transaction | CNMD | Common Stock | Sale | -$2.63K | -20 | -38.46% | $131.63 | 32 | Oct 4, 2021 | Direct | F3 |
| transaction | CNMD | Common Stock | Sale | -$4.26K | -32 | -100% | $132.99 | 0 | Oct 4, 2021 | Direct | F4 |
| transaction | CNMD | Common Stock | Options Exercise | $425K | +8.4K | $50.61 | 8.4K | Oct 4, 2021 | Direct | F5 | |
| transaction | CNMD | Common Stock | Sale | -$403K | -3.12K | -37.11% | $129.38 | 5.28K | Oct 4, 2021 | Direct | F6 |
| transaction | CNMD | Common Stock | Sale | -$401K | -3.08K | -58.36% | $130.05 | 2.2K | Oct 4, 2021 | Direct | F7 |
| transaction | CNMD | Common Stock | Sale | -$105K | -800 | -36.36% | $131.49 | 1.4K | Oct 4, 2021 | Direct | F8 |
| transaction | CNMD | Common Stock | Sale | -$119K | -900 | -64.29% | $132.65 | 500 | Oct 4, 2021 | Direct | F9 |
| transaction | CNMD | Common Stock | Sale | -$66.7K | -500 | -100% | $133.45 | 0 | Oct 4, 2021 | Direct | F10 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -8.4K | -17.5% | $0.00 | 39.6K | Oct 4, 2021 | Common Stock | 8.4K | $50.61 | Direct | F11 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.75 to $129.73. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.75 to $130.72. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.34 to $131.91. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.79 to $133.15. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F5 | All of the exercises and sales submitted on this form were subject to a written 10b5-1 plan. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.72 to $129.69. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.72 to $130.60. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.92 to $131.91. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.11 to $133.10. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.13 to $133.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F11 | Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. |